Table 3.
Dependent variable:
Δ-TC |
Model 1A | β | p |
R square
0.061 p = 0.001 |
LG-TSH | 0.150 | 0.015 | ||
LG-CRP | −0.108 | 0.094 | ||
COVID-19 severity | −0.092 | 0.155 | ||
Model 1B | β | p |
R square
0.073 p = 0.001 |
|
LG-TSH | 0.125 | 0.044 | ||
LG-CRP | −0.115 | 0.079 | ||
COVID-19 severity | −0.093 | 0.181 | ||
High CCI | 0.084 | 0.168 | ||
Anti-SARS-CoV-2 vaccination | 0.048 | 0.468 | ||
Dependent variable:
Δ-LDL-C |
Model 2A | β | p |
R square
0.077 p < 0.001 |
LG-TSH | 0.153 | 0.014 | ||
LG-CRP | −0.097 | 0.138 | ||
COVID-19 severity | −0.141 | 0.032 | ||
Model 2B | β | p |
R square
0.087 p < 0.001 |
|
LG-TSH | 0.131 | 0.036 | ||
LG-CRP | −0.101 | 0.134 | ||
COVID-19 severity | −0.130 | 0.066 | ||
High CCI | 0.052 | 0.396 | ||
Anti-SARS-CoV-2 vaccination | 0.068 | 0.314 | ||
Dependent variable:
Δ-HDL-C |
Model 3A | β | p |
R square
0.081 p < 0.001 |
Male sex | 0.160 | 0.008 | ||
LG-TSH | 0.110 | 0.075 | ||
LG-CRP | −0.134 | 0.041 | ||
COVID-19 severity | −0.106 | 0.108 | ||
Model 3B | β | p |
R square
0.118 p < 0.001 |
|
Male sex | 0.146 | 0.017 | ||
LG-TSH | 0.076 | 0.216 | ||
LG-CRP | −0.131 | 0.049 | ||
COVID-19 severity | −0.124 | 0.074 | ||
High CCI | 0.176 | 0.004 | ||
Anti-SARS-CoV-2 vaccination | 0.038 | 0.575 |
CCI, Charlson comorbidity index; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LG, logarithm; TC, total cholesterol; TSH, thyroid-stimulating hormone; Δ, variation.